
|Videos|August 1, 2020
Diabetic retinopathy progression in anti-VEGF versus FA implant (ASRS 2020)
Author(s)Alex Delaney-Gesing
Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.
Advertisement
Caesar Luo, MD, speaks with Modern Retina®/Ophthalmology Times®' Sheryl Stevenson on the take-away points from his presentation on diabetic retinopathy progression in anti-VEGF versus FA implant during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting, and how the topics from his talk may be applied day to day in retinal practice.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
2
ChatGPT-5 overestimates macular hole surgery success, study finds
3
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5


























